FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940346018> ?p ?o ?g. }

• W2940346018 endingPage "1049" @default.
• W2940346018 startingPage "1043" @default.
• W2940346018 abstract "Background Neoadjuvant chemoradiotherapy, potentially relevant to increase resection rate in pancreatic cancer, is still debated. Aims To assess tolerance, resection rate and outcomes of patients with non-metastatic pancreatic ductal adenocarcinoma treated by concomitant chemoradiotherapy. Methods This monocentric study included all consecutive patients treated from 2010 to 2014 for non-metastatic pancreatic adenocarcinoma. Chemotherapy was followed by chemoradiotherapy in operable patients, surgical resectability being assessed by CT-scan. Results Seventy-nine patients were included: 41 patients had borderline and 38 locally advanced tumours. All patients were treated by chemotherapy (FOLFIRINOX), followed by chemoradiotherapy (median dose: 59 Gy, range 45–66 Gy) for 94% of patients. Thirty-seven patients (47%) could subsequently benefit from surgery with a complete R0 resection in 94% of cases, with a postoperative mortality of 5%. Median overall survival was 21.5 months (median follow-up: 48.8 months). Local control, overall and disease-free survival were significantly higher for patients who underwent resection compared to others, with 89.2% vs 59.5% (p = 0.01), 49.7 vs 17.4 months (p < 0.01) and 25.5 vs 9.2 months (p < 0.01), respectively. Conclusion Neoadjuvant treatment consisting of FOLFIRINOX chemotherapy followed by chemoradiotherapy is an efficient strategy for patients with borderline and locally advanced pancreatic cancer, resulting in a 43% rate of secondary complete surgical resection associated with high local control, overall and disease-free survival." @default.
• W2940346018 created "2019-04-25" @default.
• W2940346018 creator A5000592480 @default.
• W2940346018 creator A5009132733 @default.
• W2940346018 creator A5021962574 @default.
• W2940346018 creator A5025235110 @default.
• W2940346018 creator A5035896683 @default.
• W2940346018 creator A5036691397 @default.
• W2940346018 creator A5038199519 @default.
• W2940346018 creator A5043045014 @default.
• W2940346018 creator A5057889505 @default.
• W2940346018 creator A5069855363 @default.
• W2940346018 creator A5077844357 @default.
• W2940346018 creator A5082631947 @default.
• W2940346018 creator A5083304167 @default.
• W2940346018 date "2019-07-01" @default.
• W2940346018 modified "2023-09-30" @default.
• W2940346018 title "FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre" @default.
• W2940346018 cites W1137482096 @default.
• W2940346018 cites W1964601821 @default.
• W2940346018 cites W1994177577 @default.
• W2940346018 cites W2007334557 @default.
• W2940346018 cites W2022501291 @default.
• W2940346018 cites W2023786153 @default.
• W2940346018 cites W2024473648 @default.
• W2940346018 cites W2043766820 @default.
• W2940346018 cites W2049412596 @default.
• W2940346018 cites W2060898028 @default.
• W2940346018 cites W2072108715 @default.
• W2940346018 cites W2072166355 @default.
• W2940346018 cites W2076408358 @default.
• W2940346018 cites W2079934168 @default.
• W2940346018 cites W2086039705 @default.
• W2940346018 cites W2086830718 @default.
• W2940346018 cites W2096998881 @default.
• W2940346018 cites W2107539963 @default.
• W2940346018 cites W2155311194 @default.
• W2940346018 cites W2165340137 @default.
• W2940346018 cites W2167628315 @default.
• W2940346018 cites W2171187859 @default.
• W2940346018 cites W2330075233 @default.
• W2940346018 cites W2345822778 @default.
• W2940346018 cites W2346921980 @default.
• W2940346018 cites W2413386818 @default.
• W2940346018 cites W2557297120 @default.
• W2940346018 cites W2565595087 @default.
• W2940346018 cites W2609928307 @default.
• W2940346018 cites W2743061229 @default.
• W2940346018 cites W2752952788 @default.
• W2940346018 doi "https://doi.org/10.1016/j.dld.2019.03.004" @default.
• W2940346018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31000479" @default.
• W2940346018 hasPublicationYear "2019" @default.
• W2940346018 type Work @default.
• W2940346018 sameAs 2940346018 @default.
• W2940346018 citedByCount "10" @default.
• W2940346018 countsByYear W29403460182019 @default.
• W2940346018 countsByYear W29403460182020 @default.
• W2940346018 countsByYear W29403460182021 @default.
• W2940346018 countsByYear W29403460182022 @default.
• W2940346018 countsByYear W29403460182023 @default.
• W2940346018 crossrefType "journal-article" @default.
• W2940346018 hasAuthorship W2940346018A5000592480 @default.
• W2940346018 hasAuthorship W2940346018A5009132733 @default.
• W2940346018 hasAuthorship W2940346018A5021962574 @default.
• W2940346018 hasAuthorship W2940346018A5025235110 @default.
• W2940346018 hasAuthorship W2940346018A5035896683 @default.
• W2940346018 hasAuthorship W2940346018A5036691397 @default.
• W2940346018 hasAuthorship W2940346018A5038199519 @default.
• W2940346018 hasAuthorship W2940346018A5043045014 @default.
• W2940346018 hasAuthorship W2940346018A5057889505 @default.
• W2940346018 hasAuthorship W2940346018A5069855363 @default.
• W2940346018 hasAuthorship W2940346018A5077844357 @default.
• W2940346018 hasAuthorship W2940346018A5082631947 @default.
• W2940346018 hasAuthorship W2940346018A5083304167 @default.
• W2940346018 hasBestOaLocation W29403460181 @default.
• W2940346018 hasConcept C121608353 @default.
• W2940346018 hasConcept C126322002 @default.
• W2940346018 hasConcept C141071460 @default.
• W2940346018 hasConcept C143998085 @default.
• W2940346018 hasConcept C2776694085 @default.
• W2940346018 hasConcept C2777148230 @default.
• W2940346018 hasConcept C2778292576 @default.
• W2940346018 hasConcept C2778424827 @default.
• W2940346018 hasConcept C2779384505 @default.
• W2940346018 hasConcept C2780210213 @default.
• W2940346018 hasConcept C2780258809 @default.
• W2940346018 hasConcept C2780962732 @default.
• W2940346018 hasConcept C2781182431 @default.
• W2940346018 hasConcept C526805850 @default.
• W2940346018 hasConcept C530470458 @default.
• W2940346018 hasConcept C71924100 @default.
• W2940346018 hasConceptScore W2940346018C121608353 @default.
• W2940346018 hasConceptScore W2940346018C126322002 @default.
• W2940346018 hasConceptScore W2940346018C141071460 @default.
• W2940346018 hasConceptScore W2940346018C143998085 @default.
• W2940346018 hasConceptScore W2940346018C2776694085 @default.
• W2940346018 hasConceptScore W2940346018C2777148230 @default.
• W2940346018 hasConceptScore W2940346018C2778292576 @default.

• next